Close Menu

NEW YORK – Oxford Immunotec on Tuesday morning reported that its first quarter revenues fell 6 percent year over year due to the impact of the COVID-19 pandemic on its sales in China.

For the three months ended March 31, the diagnostics firm with offices in Oxford, UK and Marlborough, Massachusetts brought in revenues of $13.9 million compared to $14.8 million a year ago, but ahead of the average Wall Street estimate of $13.5 million. On a constant currency basis, revenue decreased about 5 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.